Abstract CT039: Primary analysis of the EORTC 10041/ BIG 3-04 MINDACT study: a prospective, randomized study evaluating the clinical utility of the 70-gene signature (MammaPrint) combined with common clinical-pathological criteria for selection of patients for adjuvant chemotherapy in breast cancer with 0 to 3 positive nodes

Background: The MINDACT TRIAL investigated the clinical utility of the 70-gene profile (MammaPrint®), when confronted to the standard clinical pathological (CP) criteria, for the selection of patients unlikely to benefit from adjuvant chemotherapy (CT).Methods: From 2007 to 2011, 11288 patients were...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 2016-07, Vol.76 (14_Supplement), p.CT039-CT039
Hauptverfasser:	Piccart, Martine, Rutgers, Emiel, van’ t Veer, Laura, Slaets, Leen, Delaloge, Suzette, Viale, Giuseppe, Pierga, Jean Yves, Vuylsteke, Peter, Brain, Etienne, Vrijaldenhoven, Suzan, Neijenhuis, P., Coudert, Bruno, Smilde, Tineke, Gil, Miguel, Thompson, Alastair, Rubio, Isabel, Passalaqua, Rodolfo, Matos, Erika, Nitz, Urlike, Delorenzi, Mauro, Thomas, Geraldine, Goulioti, Theodora, Straehle, Carolyn, Tryfonidis, Konstantinos, Bogaerts, Jan, Cardoso, Fatima
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!